Art

J-GLOBAL ID：201502200630779714   Reference number：15A0776229

Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review

化学療法誘導の吐き気と嘔吐(CINV)の予防における最近の発展: 包括的レビュー

Author (3)： JORDAN K. (Martin Luther Univ. Halle-Wittenberg, Halle, DEU) ,  JAHN F. (Martin Luther Univ. Halle-Wittenberg, Halle, DEU) ,  AAPRO M. (Multidisciplinary Oncology Inst., Genolier, CHE)
Material： Annals of Oncology  (Ann Oncol)
Volume： 26  Issue： 6  Page： 1081-1090  Publication year： Jun. 2015 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 解説  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *NK1 receptor antagonist ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0776229&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (1)： Clinical application of drugs acting on digestive system  (GW09020B)

Substance index (3)： Netupiant/Palonosetron ,  Rolapitant ,  Olanzapine

Reference (69)：

• Hesketh PJ, Rossi G, Rizzi G et al. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study. Ann Oncol 2014; 25: 1340-1346.
• Aapro M, Rugo H, Rossi G et al. A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy. Ann Oncol 2014; 25: 1328-1333.
• Gralla RJ, Bosnjak SM, Hontsa A et al. A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy. Ann Oncol 2014; 25: 1333-1339.
• Jahn P, Jordan K, Rizzi G. Improving the functional status of patients with cancer by more effectively preventing chemotherapy-induced nausea and vomiting (CINV): results of a phase 3 study of NEPA (fixed-dose combination of netupitant and palonosetron). Eur J Oncol Nursing 2014; 18: 20-21.
• Aapro MS, Gralla R, Karthaus M et al. Multicycle efficacy and safety of NEPA, a fixed-dose antiemetic combination of netupitant and palonosetron, in patients receiving chemotherapy of varying emetogenicity. Ann Oncol 2014; 25(24): iv517-iv541.

Terms in the title (6)： 化学療法 ,  誘導 ,  吐き気と嘔吐 ,  予防 ,  発展 ,  レビュー